Personal information

Emails & domains

Verified email domains

Other IDs

Scopus Author ID: 7004735878
ResearcherID: H-3253-2011
SciProfiles: 1732062

Activities

Collapse all

Employment (15)

St. Jude Children's Research Hospital: Memphis, US

2024 to present | Senior Deputy Director, St. Jude Children's Research Hospital Comprehensive Cancer Center
Employment
Source: Self-asserted source
Charles Mullighan

St. Jude Children's Research Hospital: Memphis, US

2019 to present | Deputy Director (St. Jude Children's Research Hospital Comprehensive Cancer Center)
Employment
Source: Self-asserted source
Charles Mullighan

St. Jude Children's Research Hospital: Memphis, US

2016 to present | William E. Evans Endowed Chair
Employment
Source: Self-asserted source
Charles Mullighan

St Jude Children's Research Hospital: Memphis, TN, US

2014-05 to present | Member (Pathology)
Employment
Source: Self-asserted source
Charles Mullighan

University of Tennessee Health Science Center: Memphis, US

2014 to present | Professor (Pathology )
Employment
Source: Self-asserted source
Charles Mullighan

St. Jude Children's Research Hospital: Memphis, US

2011 to present | Co-leader (Hematologic Malignancies Program)
Employment
Source: Self-asserted source
Charles Mullighan

St. Jude Children's Research Hospital: Memphis, US

2008 to present | Medical Director, Biorespository (Pathology)
Employment
Source: Self-asserted source
Charles Mullighan

St. Jude Children's Research Hospital: Memphis, US

2011 to 2014 | Associate Member (Pathology)
Employment
Source: Self-asserted source
Charles Mullighan

St. Jude Children's Research Hospital: Memphis, US

2008 to 2011 | Assistant Member (Pathology)
Employment
Source: Self-asserted source
Charles Mullighan

St. Jude Children's Research Hospital: Memphis, US

2004 to 2008 | NH&MRC (Australia) CJ Martin Travelling Postdoctoral Fellow; Physician Scientist Postdoctoral Fellow (Pathology)
Employment
Source: Self-asserted source
Charles Mullighan

Institute of Medical and Veterinary Science: Adelaide, AU

2001 to 2003 | Trainee (Haematology/Haematopathology)
Employment
Source: Self-asserted source
Charles Mullighan

Royal Adelaide Hospital: Adelaide, AU

2001 to 2001 | Chief Medical Resident
Employment
Source: Self-asserted source
Charles Mullighan

Royal Adelaide Hospital: Adelaide, AU

1998 to 2000 | Physician Trainee (Internal Medicine Resident),
Employment
Source: Self-asserted source
Charles Mullighan

University of Oxford: Oxford, GB

1994 to 1997 | University of Adelaide George Murray Scholar and Immunology Registrar (Departments of Immunology and Transplantation Immunology)
Employment
Source: Self-asserted source
Charles Mullighan

Royal Adelaide Hospital: Adelaide, AU

1993 to 1993 | Intern
Employment
Source: Self-asserted source
Charles Mullighan

Education and qualifications (3)

University of Adelaide: Adelaide, SA, AU

1994-01-01 to 1997-12-31 | M.D. (Medicine)
Education
Source: Self-asserted source
Charles Mullighan

King's College London: London, London, GB

1994-01-01 to 1996-10-31 | M.Sc.(Hons) (Immunology)
Education
Source: Self-asserted source
Charles Mullighan

University of Adelaide: Adelaide, SA, AU

1987-01-01 to 1992-12-31 | M.B.,B.S.(Hons)
Education
Source: Self-asserted source
Charles Mullighan

Professional activities (29)

Clarivate (United States): Philadelphia, US

2022 | Highly Cited Researcher
Distinction
Source: Self-asserted source
Charles Mullighan

Clarivate (United States): Philadelphia, US

2021 | Highly Cited Researcher
Distinction
Source: Self-asserted source
Charles Mullighan

Clarivate (United States): Philadelphia, US

2020 | Highly Cited Researcher
Distinction
Source: Self-asserted source
Charles Mullighan

Society of Hematologic Oncology: Houston, US

2019 | Distinguished Lecturer
Distinction
Source: Self-asserted source
Charles Mullighan

Clarivate (United States): Philadelphia, US

2019 | Highly Cited Researcher
Distinction
Source: Self-asserted source
Charles Mullighan

Clarivate (United States): Philadelphia, US

2018 | Highly Cited Researcher
Distinction
Source: Self-asserted source
Charles Mullighan

National Cancer Institute: Bethesda, US

2017 | R35 Outstanding Investigator Award
Distinction
Source: Self-asserted source
Charles Mullighan

St. Baldrick's Foundation: Monrovia, US

2016 | Inaugural Robert J. Arceci Innovation Award
Distinction
Source: Self-asserted source
Charles Mullighan

Association of American Physicians: Washington, DC, US

2016 | Elected Member
Distinction
Source: Self-asserted source
Charles Mullighan

American Society of Hematology: Washington, D.C., US

2016 | William Dameshek Prize
Distinction
Source: Self-asserted source
Charles Mullighan

United States and Canadian Academy of Pathology: Palm Springs, US

2015 | Ramzi Cotran Young Investigator Award
Distinction
Source: Self-asserted source
Charles Mullighan

Australian Academy of Health and Medical Sciences: Brisbane, AU

2015 | Elected Fellow
Distinction
Source: Self-asserted source
Charles Mullighan

Meyenburg Foundation: Heidelberg, DE

2012 | Meyenburg Prize for Cancer Research
Distinction
Source: Self-asserted source
Charles Mullighan

American Society for Clinical Investigation: Ann Arbor, US

2012 | Elected Member
Distinction
Source: Self-asserted source
Charles Mullighan

Royal College of Pathologists of Australasia: Sydney, AU

2010 | Founding Fellow (Faculty of Science)
Distinction
Source: Self-asserted source
Charles Mullighan

Society for Pediatric Pathology: Gig Harbor, US

2009 | Lotte Strauss Prize
Distinction
Source: Self-asserted source
Charles Mullighan

Pew Charitable Trusts: Philadelphia, US

2009 | Pew Scholar in the Biomedical Sciences
Distinction
Source: Self-asserted source
Charles Mullighan

Memphis Business Journal: Memphis, TN, US

2009 | 'Health Care Heroes' Innovations Prize
Distinction
Source: Self-asserted source
Charles Mullighan

American Association For Cancer Research: Philadelphia, US

2009 | Team Science Award
Distinction
Source: Self-asserted source
Charles Mullighan

American Society of Hematology: Washington, D.C., US

2008 | Joanne Levy Memorial Award for Outstanding Achievement
Distinction
Source: Self-asserted source
Charles Mullighan

American Society of Hematology: Washington, D.C., US

2007 | Scholar Award
Distinction
Source: Self-asserted source
Charles Mullighan

American Society of Hematology: Washington, D.C., US

2007 | Merit Award
Distinction
Source: Self-asserted source
Charles Mullighan

American Association For Cancer Research: Philadelphia, US

2007 | Aflac Career Development Award
Distinction
Source: Self-asserted source
Charles Mullighan

Royal College of Pathologists of Australasia: Sydney, AU

2003 | Kanematsu Award
Distinction
Source: Self-asserted source
Charles Mullighan

Royal College of Pathologists of Australasia: Sydney, AU

2002 | D.S. Nelson Prize
Distinction
Source: Self-asserted source
Charles Mullighan

Royal Australasian College of Physicians: Sydney, AU

2002 | Pfizer Advance Trainee Prize
Distinction
Source: Self-asserted source
Charles Mullighan

Royal Australasian College of Physicians: Sydney, AU

2001 | Professor John Chalmers Prize
Distinction
Source: Self-asserted source
Charles Mullighan

Haematology Society of Australia and New Zealand: Sydney, AU

2001 | Albert Baikie Memorial Award
Distinction
Source: Self-asserted source
Charles Mullighan

University of Adelaide: Adelaide, AU

1992 | Deans List, Honors (College of Medicine)
Distinction
Source: Self-asserted source
Charles Mullighan

Funding (7)

Screening and targeting newly discovered genetic lesions in poor risk adult and childhood ALL

2013-01-01 to 2015-12-31 | Grant
National Health and Medical Research Council (Canberra, AU)
GRANT_NUMBER: 1044884
GRANT_NUMBER: 1044884
Source: Self-asserted source
Charles Mullighan via DimensionsWizard

Functional analysis of leukemic CREBBP mutations

2012-08-01 to 2017-05-31 | Grant
National Cancer Institute (Bethesda, US)
GRANT_NUMBER: 5R01CA161202-03
GRANT_NUMBER: 5R01CA161202-03
Source: Self-asserted source
Charles Mullighan via DimensionsWizard

Identifying the spectrum of genetic alterations in high risk ALL

2010-09-30 to 2013-09-29 | Grant
National Cancer Institute (Bethesda, US)
GRANT_NUMBER: 1RC4CA156329-01
GRANT_NUMBER: 1RC4CA156329-01
Source: Self-asserted source
Charles Mullighan via DimensionsWizard

Klf5 function in Acute Myeloid Leukaemia

2010-01-01 to 2012-12-31 | Grant
National Health and Medical Research Council (Canberra, AU)
GRANT_NUMBER: 626946
GRANT_NUMBER: 626946
Source: Self-asserted source
Charles Mullighan via DimensionsWizard

Targeted Therapies for Childhood Acute Lymphoblastic Leukemia

2009-09-30 to 2012-12-31 | Grant
National Cancer Institute (Bethesda, US)
GRANT_NUMBER: 5RC2CA148529-02
GRANT_NUMBER: 5RC2CA148529-02
Source: Self-asserted source
Charles Mullighan via DimensionsWizard

GENOMIC ANALYSIS OF ADOLESCENT AND YOUNG ADULT ACUTE LYMPHOBLASTIC LEUKEMIA

2009-09-30 to 2012-08-31 | Grant
National Cancer Institute (Bethesda, US)
GRANT_NUMBER: 5RC1CA145707-02
GRANT_NUMBER: 5RC1CA145707-02
Source: Self-asserted source
Charles Mullighan via DimensionsWizard

Molecular biology of acute myeloid leukaemia with alterations of core binding factor transcription complex

2004-01-01 to 2008-12-31 | Grant
National Health and Medical Research Council (Canberra, AU)
GRANT_NUMBER: 298951
GRANT_NUMBER: 298951
Source: Self-asserted source
Charles Mullighan via DimensionsWizard
How many people are using ORCID?